Gene Symbol | Gene ID | Gene Info |
---|---|---|
Neurod1
|
ENSMUSG00000034701.9 | neurogenic differentiation 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_79455189_79455414 | Neurod1 | 1450 | 0.352819 | 0.84 | 1.5e-15 | Click! |
chr2_79456334_79456528 | Neurod1 | 320 | 0.520323 | 0.81 | 6.1e-14 | Click! |
chr2_79454501_79454704 | Neurod1 | 2149 | 0.298024 | 0.76 | 1.5e-11 | Click! |
chr2_79455687_79455958 | Neurod1 | 929 | 0.419028 | 0.73 | 2.5e-10 | Click! |
chr2_79454217_79454420 | Neurod1 | 2433 | 0.283638 | 0.65 | 1.1e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_75562472_75562807 | 56.55 |
Gm11259 |
predicted gene 11259 |
181879 |
0.03 |
chr1_34182977_34183174 | 52.06 |
Dst |
dystonin |
4169 |
0.2 |
chr9_83488156_83488331 | 47.10 |
Gm28552 |
predicted gene 28552 |
8211 |
0.15 |
chr8_68830179_68830472 | 46.11 |
Ints10 |
integrator complex subunit 10 |
1468 |
0.43 |
chr14_24578363_24578849 | 45.75 |
4930542C16Rik |
RIKEN cDNA 4930542C16 gene |
38698 |
0.14 |
chr8_35933319_35934071 | 44.17 |
Gm22030 |
predicted gene, 22030 |
43883 |
0.13 |
chr1_4970686_4970886 | 43.81 |
Gm16041 |
predicted gene 16041 |
71 |
0.97 |
chr12_86699971_86700488 | 43.71 |
Angel1 |
angel homolog 1 |
5735 |
0.15 |
chr6_89613728_89614091 | 42.90 |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
18257 |
0.17 |
chr4_24631177_24631576 | 42.88 |
Klhl32 |
kelch-like 32 |
44051 |
0.17 |
chr10_93275855_93276147 | 42.54 |
Elk3 |
ELK3, member of ETS oncogene family |
34810 |
0.13 |
chr2_139311595_139311791 | 42.44 |
Gm14071 |
predicted gene 14071 |
72647 |
0.12 |
chr15_42309753_42309936 | 40.95 |
Gm49452 |
predicted gene, 49452 |
10502 |
0.2 |
chr18_19603967_19604152 | 40.81 |
Gm7720 |
predicted gene 7720 |
49099 |
0.19 |
chr13_47414007_47414186 | 40.71 |
Gm35733 |
predicted gene, 35733 |
52710 |
0.15 |
chr13_54345904_54346263 | 40.60 |
Gm48622 |
predicted gene, 48622 |
18203 |
0.14 |
chr3_26146228_26146427 | 40.46 |
Nlgn1 |
neuroligin 1 |
6980 |
0.33 |
chr5_60600153_60600339 | 40.16 |
Gm43390 |
predicted gene 43390 |
21616 |
0.23 |
chr10_109684648_109684819 | 39.75 |
3110043J17Rik |
RIKEN cDNA 3110043J17 gene |
35954 |
0.19 |
chr11_18413972_18414175 | 39.10 |
Gm37869 |
predicted gene, 37869 |
22169 |
0.21 |
chr9_112102522_112102731 | 38.71 |
Mir128-2 |
microRNA 128-2 |
16085 |
0.25 |
chr15_10075808_10075980 | 38.57 |
Prlr |
prolactin receptor |
101344 |
0.08 |
chr16_77852087_77852674 | 38.24 |
Gm17333 |
predicted gene, 17333 |
5776 |
0.27 |
chr5_78622542_78622942 | 37.97 |
Gm43232 |
predicted gene 43232 |
82214 |
0.11 |
chr5_37247497_37247695 | 37.68 |
Crmp1 |
collapsin response mediator protein 1 |
311 |
0.9 |
chr9_23693175_23693371 | 36.88 |
Gm3011 |
predicted gene 3011 |
83219 |
0.1 |
chr19_26382195_26382350 | 36.72 |
Gm50377 |
predicted gene, 50377 |
73565 |
0.09 |
chr3_63616179_63616468 | 36.45 |
Plch1 |
phospholipase C, eta 1 |
85720 |
0.08 |
chr5_89814676_89814843 | 36.41 |
Gm25758 |
predicted gene, 25758 |
14112 |
0.27 |
chr10_118121607_118122166 | 36.37 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
9369 |
0.16 |
chr17_61513606_61513769 | 36.32 |
Gm6174 |
predicted gene 6174 |
116377 |
0.07 |
chr7_40901199_40901451 | 36.25 |
A230077H06Rik |
RIKEN cDNA A230077H06 gene |
388 |
0.72 |
chr10_101373884_101374182 | 36.24 |
Gm19233 |
predicted gene, 19233 |
102412 |
0.08 |
chr9_58111541_58111738 | 36.04 |
Ccdc33 |
coiled-coil domain containing 33 |
2721 |
0.19 |
chr6_93819932_93820284 | 36.02 |
Gm23035 |
predicted gene, 23035 |
26336 |
0.19 |
chr6_138754991_138755232 | 35.90 |
Igbp1b |
immunoglobulin (CD79A) binding protein 1b |
96567 |
0.08 |
chr16_16559483_16559649 | 35.63 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
424 |
0.84 |
chr14_113469187_113469363 | 35.29 |
Gm4487 |
predicted gene 4487 |
21385 |
0.28 |
chr15_57162853_57163046 | 35.19 |
Gm26178 |
predicted gene, 26178 |
76164 |
0.11 |
chr8_25465368_25465990 | 35.15 |
Gm10689 |
predicted gene 10689 |
11406 |
0.11 |
chr2_66158204_66158355 | 35.11 |
Gm13616 |
predicted gene 13616 |
12404 |
0.17 |
chr4_133509054_133509342 | 35.11 |
Kdf1 |
keratinocyte differentiation factor 1 |
9765 |
0.1 |
chr1_153045499_153045654 | 34.90 |
Nmnat2 |
nicotinamide nucleotide adenylyltransferase 2 |
12202 |
0.2 |
chr12_44338422_44338729 | 34.68 |
Nrcam |
neuronal cell adhesion molecule |
9325 |
0.18 |
chr6_113860653_113861093 | 34.55 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
30497 |
0.13 |
chr6_55646252_55646782 | 34.13 |
Neurod6 |
neurogenic differentiation 6 |
34746 |
0.17 |
chr14_124195911_124196083 | 34.12 |
Fgf14 |
fibroblast growth factor 14 |
3095 |
0.38 |
chr3_37964126_37964277 | 33.99 |
Gm7799 |
predicted gene 7799 |
4114 |
0.2 |
chr3_107431308_107431650 | 33.90 |
Kcnc4 |
potassium voltage gated channel, Shaw-related subfamily, member 4 |
28073 |
0.15 |
chr8_4206127_4207837 | 33.83 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr6_55680988_55681310 | 33.22 |
Neurod6 |
neurogenic differentiation 6 |
114 |
0.97 |
chr3_104058968_104059448 | 33.17 |
Gm42696 |
predicted gene 42696 |
1067 |
0.33 |
chr4_110287470_110287673 | 33.17 |
Elavl4 |
ELAV like RNA binding protein 4 |
44 |
0.99 |
chr7_50241955_50242168 | 32.81 |
Nell1 |
NEL-like 1 |
143751 |
0.05 |
chr13_29823931_29824236 | 32.61 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
31348 |
0.22 |
chr10_14332916_14333150 | 32.45 |
Gm48854 |
predicted gene, 48854 |
5622 |
0.19 |
chr14_93039972_93040145 | 32.35 |
Gm23509 |
predicted gene, 23509 |
98131 |
0.08 |
chr5_132170183_132170377 | 32.33 |
Gm42995 |
predicted gene 42995 |
32888 |
0.16 |
chr11_3853578_3853769 | 32.32 |
Osbp2 |
oxysterol binding protein 2 |
10230 |
0.12 |
chrX_166147535_166147731 | 32.17 |
Gemin8 |
gem nuclear organelle associated protein 8 |
22821 |
0.2 |
chr7_19075475_19075761 | 31.98 |
Dmwd |
dystrophia myotonica-containing WD repeat motif |
609 |
0.48 |
chr6_51849053_51849306 | 31.69 |
Skap2 |
src family associated phosphoprotein 2 |
22750 |
0.22 |
chr4_123053299_123053489 | 31.67 |
Trit1 |
tRNA isopentenyltransferase 1 |
4638 |
0.16 |
chr2_125209362_125209539 | 31.65 |
Gm14002 |
predicted gene 14002 |
8062 |
0.17 |
chr3_127651845_127652045 | 31.52 |
Neurog2 |
neurogenin 2 |
18810 |
0.11 |
chr5_116592430_116592766 | 31.46 |
Srrm4 |
serine/arginine repetitive matrix 4 |
781 |
0.64 |
chr2_154421078_154421682 | 31.43 |
Snta1 |
syntrophin, acidic 1 |
13281 |
0.16 |
chr1_58739776_58739943 | 31.34 |
Cflar |
CASP8 and FADD-like apoptosis regulator |
9307 |
0.14 |
chr3_4796668_4797120 | 31.27 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
664 |
0.77 |
chr9_42187408_42187734 | 31.25 |
4930546K05Rik |
RIKEN cDNA 4930546K05 gene |
21642 |
0.17 |
chr17_37073045_37073202 | 31.14 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
2679 |
0.13 |
chr15_100909968_100910181 | 31.05 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
23355 |
0.17 |
chr7_97387069_97387256 | 31.04 |
Alg8 |
asparagine-linked glycosylation 8 (alpha-1,3-glucosyltransferase) |
60 |
0.96 |
chr11_69552572_69552936 | 30.83 |
Dnah2 |
dynein, axonemal, heavy chain 2 |
3644 |
0.1 |
chr13_96175655_96175853 | 30.76 |
Gm29543 |
predicted gene 29543 |
42385 |
0.13 |
chr4_63290951_63291422 | 30.72 |
Col27a1 |
collagen, type XXVII, alpha 1 |
7673 |
0.16 |
chr14_115821750_115821966 | 30.54 |
Gm20713 |
predicted gene 20713 |
49420 |
0.19 |
chr19_28088001_28088445 | 30.48 |
Gm28228 |
predicted gene 28228 |
633 |
0.76 |
chr12_35853279_35853501 | 30.35 |
Gm9472 |
predicted gene 9472 |
34126 |
0.16 |
chr2_13575918_13576451 | 30.33 |
Vim |
vimentin |
1661 |
0.43 |
chrX_50753571_50753722 | 30.29 |
Stk26 |
serine/threonine kinase 26 |
87401 |
0.09 |
chr10_52742737_52743261 | 30.25 |
Gm47624 |
predicted gene, 47624 |
49161 |
0.11 |
chr1_32701402_32701553 | 30.24 |
Gm37426 |
predicted gene, 37426 |
8702 |
0.27 |
chr17_49703622_49703788 | 30.13 |
Kif6 |
kinesin family member 6 |
10405 |
0.27 |
chr1_62784055_62784277 | 29.84 |
Gm37121 |
predicted gene, 37121 |
25136 |
0.17 |
chr1_61913022_61913173 | 29.84 |
Pard3bos1 |
par-3 family cell polarity regulator beta, opposite strand 1 |
61557 |
0.12 |
chr2_162282115_162282295 | 29.77 |
Ptprtos |
protein tyrosine phosphatase, receptor type T, opposite strand |
108608 |
0.07 |
chr12_26191779_26191986 | 29.76 |
Gm29687 |
predicted gene, 29687 |
18623 |
0.17 |
chr17_73712040_73712250 | 29.71 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
1692 |
0.41 |
chr1_57040318_57040506 | 29.44 |
9130024F11Rik |
RIKEN cDNA 9130024F11 gene |
19 |
0.98 |
chr5_44474212_44474578 | 29.43 |
Gm42981 |
predicted gene 42981 |
21026 |
0.13 |
chr6_48188469_48188620 | 29.42 |
Gm16630 |
predicted gene, 16630 |
29264 |
0.16 |
chr15_10655238_10655729 | 29.37 |
Gm10389 |
predicted gene 10389 |
55146 |
0.1 |
chr1_54640255_54640417 | 29.35 |
Ankrd44 |
ankyrin repeat domain 44 |
8277 |
0.2 |
chr3_109995413_109995585 | 29.33 |
Gm12535 |
predicted gene 12535 |
88115 |
0.09 |
chr16_96843761_96843947 | 29.29 |
Gm32432 |
predicted gene, 32432 |
74878 |
0.11 |
chr15_85403238_85403735 | 29.27 |
Gm23517 |
predicted gene, 23517 |
52232 |
0.12 |
chr2_72529777_72530025 | 29.24 |
Rps13-ps8 |
ribosmal protein S13, pseudogene 8 |
15311 |
0.19 |
chr8_36993069_36993405 | 29.17 |
AI429214 |
expressed sequence AI429214 |
367 |
0.85 |
chr5_103336083_103336307 | 29.15 |
Gm42619 |
predicted gene 42619 |
7777 |
0.16 |
chr18_52847997_52848328 | 29.15 |
Sncaip |
synuclein, alpha interacting protein (synphilin) |
10152 |
0.23 |
chr12_92292877_92293078 | 29.12 |
Gm6841 |
predicted gene 6841 |
73600 |
0.12 |
chr16_87567629_87567949 | 29.09 |
Map3k7cl |
Map3k7 C-terminal like |
14459 |
0.14 |
chr14_55053693_55054126 | 29.03 |
Zfhx2os |
zinc finger homeobox 2, opposite strand |
38 |
0.92 |
chr4_82946256_82946439 | 28.96 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
5465 |
0.26 |
chr18_90031804_90031989 | 28.84 |
Gm6173 |
predicted gene 6173 |
12817 |
0.27 |
chr4_66401473_66401671 | 28.76 |
Astn2 |
astrotactin 2 |
2911 |
0.36 |
chr9_27337148_27337299 | 28.65 |
Igsf9b |
immunoglobulin superfamily, member 9B |
10283 |
0.2 |
chr3_56362688_56362882 | 28.42 |
Gm25727 |
predicted gene, 25727 |
82627 |
0.1 |
chr1_83748985_83749282 | 28.32 |
Gm25754 |
predicted gene, 25754 |
46779 |
0.18 |
chr10_92557111_92557354 | 28.28 |
Gm4800 |
predicted gene 4800 |
13562 |
0.16 |
chr3_147182405_147182640 | 28.19 |
Gm6074 |
predicted gene 6074 |
10396 |
0.28 |
chr15_4376319_4376560 | 28.19 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
935 |
0.71 |
chrX_166779633_166779805 | 28.16 |
Rpl7a-ps11 |
ribosomal protein L7A, pseudogene 11 |
74492 |
0.09 |
chr7_109326930_109327106 | 28.11 |
Gm9105 |
predicted gene 9105 |
61857 |
0.1 |
chr14_28958692_28959011 | 28.03 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
10562 |
0.23 |
chr11_35857466_35857641 | 27.99 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
3999 |
0.22 |
chr4_42943208_42943374 | 27.95 |
Phf24 |
PHD finger protein 24 |
5037 |
0.13 |
chr8_31044311_31044473 | 27.79 |
Gm45252 |
predicted gene 45252 |
40484 |
0.14 |
chr14_73469713_73469864 | 27.65 |
Gm4266 |
predicted gene 4266 |
23305 |
0.16 |
chr6_33874358_33874540 | 27.65 |
Exoc4 |
exocyst complex component 4 |
12349 |
0.27 |
chr1_98350139_98350290 | 27.53 |
Slco6d1 |
solute carrier organic anion transporter family, member 6d1 |
70910 |
0.1 |
chr12_25871193_25871842 | 27.50 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr16_40228777_40228964 | 27.42 |
Gm22543 |
predicted gene, 22543 |
77349 |
0.1 |
chr4_46889165_46889490 | 27.38 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
29425 |
0.2 |
chr18_11905616_11905782 | 27.29 |
Gm49968 |
predicted gene, 49968 |
7432 |
0.22 |
chr10_31873449_31873894 | 27.28 |
Gm47704 |
predicted gene, 47704 |
5759 |
0.31 |
chr1_39947591_39947985 | 27.22 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
16367 |
0.22 |
chr15_52161658_52161900 | 27.07 |
Gm2387 |
predicted gene 2387 |
72471 |
0.1 |
chr5_24018696_24018859 | 26.99 |
Gm6745 |
predicted gene 6745 |
8365 |
0.16 |
chr15_10421430_10421775 | 26.97 |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
28390 |
0.15 |
chr7_89464155_89464325 | 26.94 |
AI314278 |
expressed sequence AI314278 |
37901 |
0.11 |
chr4_91589820_91589971 | 26.92 |
Gm12668 |
predicted gene 12668 |
36694 |
0.18 |
chr17_8961185_8961336 | 26.84 |
Pde10a |
phosphodiesterase 10A |
15691 |
0.22 |
chr7_87787683_87787842 | 26.82 |
Gm44926 |
predicted gene 44926 |
15195 |
0.27 |
chr4_55077601_55077829 | 26.78 |
Gm12515 |
predicted gene 12515 |
38848 |
0.15 |
chr11_47248441_47248592 | 26.78 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
131006 |
0.06 |
chr2_146414780_146414972 | 26.77 |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
2000 |
0.44 |
chr2_43323831_43324023 | 26.72 |
Gm13464 |
predicted gene 13464 |
195471 |
0.03 |
chr19_21742139_21742471 | 26.68 |
Gm50129 |
predicted gene, 50129 |
13035 |
0.2 |
chr2_92916283_92916463 | 26.67 |
Syt13 |
synaptotagmin XIII |
1275 |
0.42 |
chr5_112020893_112021044 | 26.65 |
Gm42488 |
predicted gene 42488 |
76733 |
0.09 |
chr3_39460563_39460812 | 26.60 |
Gm9845 |
predicted pseudogene 9845 |
101784 |
0.08 |
chr6_99968982_99969196 | 26.55 |
Gm44442 |
predicted gene, 44442 |
18158 |
0.18 |
chr3_54835428_54835616 | 26.47 |
Gm10254 |
predicted gene 10254 |
24272 |
0.15 |
chr1_23846411_23846598 | 26.42 |
Smap1 |
small ArfGAP 1 |
1273 |
0.57 |
chr14_66910406_66910614 | 26.40 |
Pnma2 |
paraneoplastic antigen MA2 |
660 |
0.64 |
chr3_120898327_120898653 | 26.35 |
6530403H02Rik |
RIKEN cDNA 6530403H02 gene |
11757 |
0.27 |
chr12_44839950_44840386 | 26.35 |
Gm15901 |
predicted gene 15901 |
83012 |
0.1 |
chr2_6594788_6595061 | 26.34 |
Celf2 |
CUGBP, Elav-like family member 2 |
2124 |
0.42 |
chr13_73117493_73117685 | 26.32 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
115806 |
0.06 |
chr14_13652086_13652293 | 26.27 |
Sntn |
sentan, cilia apical structure protein |
18687 |
0.24 |
chr13_63552583_63552875 | 26.25 |
Ptch1 |
patched 1 |
7413 |
0.15 |
chr6_113861156_113861350 | 26.25 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
30117 |
0.13 |
chr3_18206079_18206269 | 26.23 |
Gm23686 |
predicted gene, 23686 |
28549 |
0.18 |
chr3_38299580_38299934 | 26.20 |
Gm42920 |
predicted gene 42920 |
69641 |
0.09 |
chr6_39242951_39243777 | 26.12 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr11_32941466_32941648 | 26.09 |
Gm12111 |
predicted gene 12111 |
15397 |
0.16 |
chr5_103497567_103497760 | 26.04 |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
31903 |
0.15 |
chr7_91514516_91514667 | 26.03 |
Gm44679 |
predicted gene 44679 |
4524 |
0.21 |
chr13_54309432_54309638 | 26.01 |
Gm48623 |
predicted gene, 48623 |
6977 |
0.17 |
chr4_31366167_31366509 | 26.01 |
Gm11922 |
predicted gene 11922 |
14134 |
0.31 |
chr8_57436208_57436392 | 25.99 |
Scrg1 |
scrapie responsive gene 1 |
19623 |
0.12 |
chr17_43952334_43952615 | 25.94 |
Rcan2 |
regulator of calcineurin 2 |
525 |
0.86 |
chr10_17202862_17203093 | 25.93 |
Gm25382 |
predicted gene, 25382 |
86173 |
0.09 |
chr14_93463482_93463633 | 25.91 |
Gm48964 |
predicted gene, 48964 |
152420 |
0.04 |
chr1_52524166_52524337 | 25.91 |
Gm553 |
predicted gene 553 |
1349 |
0.3 |
chr3_106131787_106131964 | 25.88 |
Chia1 |
chitinase, acidic 1 |
9421 |
0.14 |
chr3_65455899_65456285 | 25.84 |
Gm34780 |
predicted gene, 34780 |
38943 |
0.1 |
chr17_50407363_50407533 | 25.83 |
Gm49906 |
predicted gene, 49906 |
68196 |
0.11 |
chr18_33151119_33151270 | 25.77 |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
62572 |
0.13 |
chr5_97289441_97289719 | 25.75 |
Gm5560 |
predicted pseudogene 5560 |
24752 |
0.17 |
chr11_71439882_71440106 | 25.69 |
Gm16013 |
predicted gene 16013 |
3814 |
0.28 |
chr12_78001910_78002237 | 25.62 |
Gm24994 |
predicted gene, 24994 |
163473 |
0.03 |
chr1_176929699_176930074 | 25.61 |
Gm15423 |
predicted gene 15423 |
2825 |
0.2 |
chr5_64023065_64023283 | 25.60 |
Gm25608 |
predicted gene, 25608 |
20690 |
0.13 |
chr5_78585024_78585202 | 25.58 |
Gm43232 |
predicted gene 43232 |
44585 |
0.2 |
chr6_48221834_48222128 | 25.55 |
Gm16630 |
predicted gene, 16630 |
62701 |
0.09 |
chr7_25676228_25676843 | 25.54 |
Tmem91 |
transmembrane protein 91 |
1369 |
0.23 |
chr19_41697481_41697772 | 25.52 |
Slit1 |
slit guidance ligand 1 |
45860 |
0.14 |
chr18_78495605_78496010 | 25.43 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
18657 |
0.22 |
chr12_72285400_72285701 | 25.39 |
Rtn1 |
reticulon 1 |
48826 |
0.15 |
chr5_142692379_142692530 | 25.29 |
Slc29a4 |
solute carrier family 29 (nucleoside transporters), member 4 |
58 |
0.97 |
chr10_43602124_43602294 | 25.13 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
8770 |
0.14 |
chr4_107829775_107830223 | 25.04 |
Lrp8os1 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, opposite strand 1 |
845 |
0.35 |
chr12_27646544_27646940 | 24.96 |
Gm24326 |
predicted gene, 24326 |
14939 |
0.26 |
chr4_97575544_97575736 | 24.92 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
8956 |
0.22 |
chr8_45755686_45755837 | 24.91 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
7347 |
0.19 |
chr7_49199462_49199658 | 24.74 |
Gm37613 |
predicted gene, 37613 |
4019 |
0.25 |
chr14_9329829_9330086 | 24.65 |
Gm48370 |
predicted gene, 48370 |
70667 |
0.13 |
chr2_4436351_4436936 | 24.62 |
Gm13175 |
predicted gene 13175 |
30027 |
0.16 |
chr16_64329729_64329949 | 24.61 |
Csnka2ip |
casein kinase 2, alpha prime interacting protein |
149309 |
0.05 |
chr4_83233208_83233369 | 24.57 |
Ttc39b |
tetratricopeptide repeat domain 39B |
118 |
0.97 |
chr3_139023701_139023892 | 24.53 |
Rap1gds1 |
RAP1, GTP-GDP dissociation stimulator 1 |
39259 |
0.16 |
chr9_80227036_80227214 | 24.53 |
Myo6 |
myosin VI |
9488 |
0.22 |
chr2_85213874_85214029 | 24.45 |
Lrrc55 |
leucine rich repeat containing 55 |
16754 |
0.11 |
chr10_87351663_87352183 | 24.44 |
Gm23191 |
predicted gene, 23191 |
12223 |
0.23 |
chr1_177150301_177150519 | 24.44 |
Gm38146 |
predicted gene, 38146 |
14957 |
0.16 |
chr13_39571276_39571508 | 24.43 |
Gm47352 |
predicted gene, 47352 |
191 |
0.95 |
chr9_35268034_35268292 | 24.35 |
Rpusd4 |
RNA pseudouridylate synthase domain containing 4 |
298 |
0.52 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
10.4 | 41.5 | GO:0030035 | microspike assembly(GO:0030035) |
7.8 | 23.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
7.3 | 22.0 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
7.1 | 28.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
5.5 | 22.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
5.5 | 16.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.2 | 20.8 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
5.2 | 25.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
4.9 | 14.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
4.9 | 14.8 | GO:0030421 | defecation(GO:0030421) |
4.9 | 44.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
4.9 | 49.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
4.7 | 14.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
4.6 | 23.2 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
4.6 | 31.9 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
4.5 | 13.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
4.4 | 17.4 | GO:0007412 | axon target recognition(GO:0007412) |
4.4 | 4.4 | GO:2000981 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
3.9 | 7.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
3.8 | 11.3 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
3.7 | 11.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.7 | 48.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
3.6 | 18.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.4 | 10.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
3.4 | 10.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
3.4 | 10.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
3.3 | 9.9 | GO:0030576 | Cajal body organization(GO:0030576) |
3.3 | 9.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.2 | 9.7 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
3.2 | 42.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
3.2 | 12.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
3.1 | 12.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
3.1 | 9.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
3.0 | 9.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.9 | 41.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
2.9 | 2.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
2.9 | 8.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.9 | 11.7 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
2.9 | 8.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.8 | 14.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
2.8 | 2.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
2.8 | 8.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.8 | 22.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.7 | 5.4 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
2.7 | 13.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
2.6 | 5.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.6 | 7.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.6 | 7.8 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.5 | 7.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.5 | 20.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
2.5 | 7.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
2.5 | 2.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
2.5 | 7.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.5 | 7.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.5 | 7.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.5 | 9.8 | GO:0035627 | ceramide transport(GO:0035627) |
2.4 | 9.6 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
2.4 | 7.2 | GO:0030070 | insulin processing(GO:0030070) |
2.3 | 7.0 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
2.3 | 25.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.3 | 7.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.3 | 11.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
2.3 | 9.1 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
2.2 | 6.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
2.2 | 6.7 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
2.2 | 11.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.2 | 4.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.2 | 8.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.2 | 6.6 | GO:0001927 | exocyst assembly(GO:0001927) |
2.2 | 2.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.2 | 4.3 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
2.2 | 8.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
2.2 | 15.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
2.2 | 12.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
2.1 | 4.3 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
2.1 | 4.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.1 | 19.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
2.1 | 6.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
2.1 | 10.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
2.1 | 16.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
2.1 | 14.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.0 | 6.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.0 | 2.0 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
2.0 | 14.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
2.0 | 8.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
2.0 | 2.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.0 | 5.9 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.9 | 5.8 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.9 | 5.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.9 | 15.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.9 | 20.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.9 | 5.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.9 | 7.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.9 | 3.7 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.8 | 3.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.8 | 3.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.8 | 3.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.8 | 5.4 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.8 | 3.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.8 | 5.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.8 | 5.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.8 | 1.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.8 | 1.8 | GO:0051938 | L-glutamate import(GO:0051938) |
1.7 | 8.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.7 | 7.0 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.7 | 10.4 | GO:0022605 | oogenesis stage(GO:0022605) |
1.7 | 6.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.7 | 10.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.7 | 6.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.7 | 8.4 | GO:0046618 | drug export(GO:0046618) |
1.7 | 5.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.7 | 8.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
1.7 | 5.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.7 | 3.3 | GO:0021564 | vagus nerve development(GO:0021564) |
1.7 | 6.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.7 | 1.7 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
1.6 | 4.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.6 | 6.6 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.6 | 4.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.6 | 4.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.6 | 11.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.6 | 3.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.6 | 12.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.6 | 6.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.6 | 7.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.6 | 4.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.6 | 4.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.5 | 6.2 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.5 | 7.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.5 | 4.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.5 | 6.1 | GO:0030091 | protein repair(GO:0030091) |
1.5 | 6.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.5 | 18.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.5 | 4.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.5 | 22.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.5 | 4.5 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
1.5 | 4.5 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.5 | 4.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.5 | 5.9 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.5 | 11.8 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
1.5 | 5.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.5 | 7.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.5 | 1.5 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.4 | 1.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.4 | 2.9 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.4 | 5.7 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.4 | 4.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.4 | 4.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.4 | 2.8 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.4 | 8.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.4 | 2.8 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.4 | 4.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.4 | 4.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.4 | 7.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
1.4 | 5.5 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
1.4 | 13.8 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
1.4 | 5.4 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
1.4 | 4.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.4 | 2.7 | GO:0048664 | neuron fate determination(GO:0048664) |
1.4 | 5.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.3 | 4.0 | GO:0008050 | female courtship behavior(GO:0008050) |
1.3 | 2.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.3 | 17.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.3 | 3.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.3 | 2.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.3 | 3.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.3 | 2.6 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
1.3 | 2.6 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
1.3 | 5.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.3 | 12.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.3 | 2.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.3 | 17.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
1.2 | 9.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.2 | 3.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.2 | 3.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.2 | 13.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.2 | 6.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
1.2 | 9.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.2 | 22.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.2 | 18.9 | GO:0060384 | innervation(GO:0060384) |
1.2 | 15.3 | GO:0008038 | neuron recognition(GO:0008038) |
1.2 | 17.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.2 | 2.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.2 | 7.0 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.2 | 4.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.2 | 2.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
1.2 | 3.5 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.1 | 3.4 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.1 | 2.3 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.1 | 2.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.1 | 3.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.1 | 4.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.1 | 1.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.1 | 2.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.1 | 4.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.1 | 8.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
1.1 | 3.3 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.1 | 2.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
1.1 | 3.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.1 | 5.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.1 | 2.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.1 | 8.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.1 | 2.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.1 | 3.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.1 | 34.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
1.0 | 4.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.0 | 3.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.0 | 2.1 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
1.0 | 10.2 | GO:0033574 | response to testosterone(GO:0033574) |
1.0 | 4.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 3.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.0 | 8.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
1.0 | 15.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
1.0 | 10.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
1.0 | 6.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.0 | 2.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.0 | 6.0 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
1.0 | 4.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.0 | 7.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.0 | 2.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.0 | 3.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.0 | 2.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.0 | 2.9 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.0 | 1.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.0 | 2.9 | GO:0015888 | thiamine transport(GO:0015888) |
1.0 | 3.8 | GO:0032202 | telomere assembly(GO:0032202) |
1.0 | 1.9 | GO:0051665 | membrane raft localization(GO:0051665) |
1.0 | 1.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.9 | 0.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.9 | 22.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.9 | 2.8 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.9 | 4.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.9 | 2.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.9 | 4.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.9 | 0.9 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.9 | 2.8 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.9 | 6.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.9 | 3.7 | GO:0070295 | renal water absorption(GO:0070295) |
0.9 | 13.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.9 | 2.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.9 | 3.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.9 | 2.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.9 | 2.7 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.9 | 0.9 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.9 | 4.6 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.9 | 20.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.9 | 3.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.9 | 5.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 18.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.9 | 8.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.9 | 4.4 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.9 | 7.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.9 | 3.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.9 | 4.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 0.9 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.9 | 2.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.9 | 1.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.9 | 1.7 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.9 | 7.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.9 | 11.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.9 | 1.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.9 | 4.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.9 | 2.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.9 | 7.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.9 | 2.6 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.9 | 1.7 | GO:0002730 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.9 | 2.6 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.8 | 1.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.8 | 0.8 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.8 | 1.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.8 | 15.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.8 | 0.8 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.8 | 6.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 1.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.8 | 1.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.8 | 2.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.8 | 2.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.8 | 1.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.8 | 0.8 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.8 | 1.6 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.8 | 0.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.8 | 7.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.8 | 2.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.8 | 4.7 | GO:0034776 | response to histamine(GO:0034776) |
0.8 | 3.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.8 | 0.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.8 | 4.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 4.6 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.8 | 2.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.8 | 2.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.8 | 2.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.8 | 7.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.8 | 2.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.7 | 3.7 | GO:0021955 | central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
0.7 | 2.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 64.8 | GO:0007612 | learning(GO:0007612) |
0.7 | 0.7 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.7 | 0.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 5.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.7 | 1.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.7 | 0.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.7 | 1.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 7.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.7 | 4.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.7 | 2.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.7 | 2.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 4.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.7 | 14.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.7 | 2.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 2.8 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.7 | 8.4 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.7 | 1.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.7 | 0.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.7 | 10.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 1.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.7 | 4.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.7 | 2.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.7 | 0.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.7 | 0.7 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.7 | 3.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 3.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.7 | 0.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.6 | 2.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.6 | 1.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.6 | 7.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.6 | 1.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.6 | 5.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.6 | 2.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 2.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.6 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 1.9 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.6 | 0.6 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.6 | 21.9 | GO:0006400 | tRNA modification(GO:0006400) |
0.6 | 3.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.6 | 1.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.6 | 1.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.6 | 1.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 6.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 1.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.6 | 3.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 0.6 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.6 | 1.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 3.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.6 | 6.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 1.8 | GO:0009414 | response to water deprivation(GO:0009414) |
0.6 | 3.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.6 | 1.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.6 | 1.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.6 | 0.6 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.6 | 9.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 0.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 2.4 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.6 | 0.6 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.6 | 10.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 2.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.6 | 2.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 1.8 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.6 | 1.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 1.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.6 | 1.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.6 | 0.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.6 | 2.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.6 | 1.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 2.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.6 | 2.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.6 | 0.6 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.6 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.6 | 4.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.6 | 1.7 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.6 | 0.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 1.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.6 | 1.7 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.6 | 1.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 1.1 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.6 | 1.7 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.6 | 4.4 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.6 | 0.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.5 | 0.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.5 | 1.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.5 | 1.6 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 3.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 4.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.5 | 1.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.5 | 2.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.5 | 1.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 1.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.5 | 0.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.5 | 1.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 0.5 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.5 | 3.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.5 | 16.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 2.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 1.6 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.5 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 0.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.5 | 0.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 2.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 4.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.5 | 1.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.5 | 4.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.5 | 2.1 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 2.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.5 | 4.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.5 | 0.5 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.5 | 0.5 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.5 | 1.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 2.0 | GO:0032351 | negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of hormone metabolic process(GO:0032351) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.5 | 2.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.5 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 4.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.5 | 1.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.5 | 1.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.5 | 1.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 5.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.5 | 1.0 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.5 | 1.0 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.5 | 1.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.5 | 4.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.5 | 2.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 1.9 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.5 | 0.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.5 | 0.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.5 | 10.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.5 | 3.7 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.5 | 6.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.5 | 3.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 1.4 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.5 | 0.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 0.5 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.5 | 0.5 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 1.4 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 3.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 8.2 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.5 | 1.4 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.5 | 3.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 0.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 0.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.5 | 0.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 1.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.5 | 1.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 3.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 2.2 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.4 | 1.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 1.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 1.8 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.4 | 1.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.9 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 1.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.4 | 18.3 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.4 | 2.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 0.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 | 1.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.4 | 1.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.4 | 2.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.4 | 1.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 2.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 1.7 | GO:0001662 | behavioral fear response(GO:0001662) |
0.4 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 0.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 0.8 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.4 | 0.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.4 | 1.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.4 | 0.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.4 | 2.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 2.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.4 | 1.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 1.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 7.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.4 | 4.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 2.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 0.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 2.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.4 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 2.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.4 | 1.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.4 | 1.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.4 | 0.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.4 | 1.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.4 | 0.8 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.4 | 1.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 0.4 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.4 | 1.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 3.6 | GO:0015816 | glycine transport(GO:0015816) |
0.4 | 2.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.4 | 0.4 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 1.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 0.4 | GO:0034238 | macrophage fusion(GO:0034238) |
0.4 | 2.0 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.4 | 1.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 2.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 17.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.4 | 2.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.4 | 3.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.4 | 0.4 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.4 | 1.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.4 | 7.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.4 | 1.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.4 | 1.1 | GO:0015824 | proline transport(GO:0015824) |
0.4 | 0.8 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.4 | 4.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.4 | 4.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.4 | 0.7 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 1.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 2.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 1.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 1.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 5.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 2.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 0.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 3.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.4 | 2.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.4 | 0.7 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.4 | 2.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.4 | 1.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 1.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 1.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 0.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 5.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.3 | 1.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 0.7 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.3 | 1.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 4.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.3 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 1.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 1.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 1.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 4.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 0.3 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.3 | 4.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 3.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 3.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.7 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
0.3 | 1.0 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 1.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 1.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 0.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 8.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 1.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 2.6 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 0.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 1.9 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 8.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 5.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.3 | 0.6 | GO:0070268 | cornification(GO:0070268) |
0.3 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 1.3 | GO:0014889 | muscle atrophy(GO:0014889) |
0.3 | 2.9 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 1.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.3 | 0.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.9 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 0.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 0.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 0.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 4.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 4.0 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 1.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 0.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.3 | 4.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.3 | 0.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.3 | 1.8 | GO:0001895 | retina homeostasis(GO:0001895) |
0.3 | 2.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 2.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 1.8 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.3 | 0.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 6.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 1.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.6 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.3 | 2.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.3 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.3 | 6.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 0.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 0.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 1.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 1.4 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 1.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 1.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 1.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 | 3.9 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.3 | 2.9 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.3 | 0.8 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.3 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 0.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.8 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.3 | 0.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.3 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.3 | GO:0032342 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) |
0.3 | 0.5 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 9.3 | GO:0015844 | monoamine transport(GO:0015844) |
0.3 | 0.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.2 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) collecting duct development(GO:0072044) |
0.2 | 0.7 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
0.2 | 0.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 2.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 1.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 1.2 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 4.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 1.9 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.2 | 4.6 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.2 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.2 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.2 | 2.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 2.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 0.2 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.2 | 0.9 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 1.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 3.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 3.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 0.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.5 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.7 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 3.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.2 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 6.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 1.6 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.7 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 1.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 1.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.2 | 0.7 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 1.8 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.2 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.2 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.2 | 1.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.9 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 3.8 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 3.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.8 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 1.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 2.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 1.2 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.2 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 0.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 1.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.4 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.2 | 0.2 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 0.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 1.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 1.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 0.4 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 0.5 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 4.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.2 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 0.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 1.8 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.2 | 0.9 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.7 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.2 | 0.2 | GO:0014075 | response to amine(GO:0014075) |
0.2 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 1.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 2.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.3 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 0.7 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.2 | 2.4 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.2 | 1.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.8 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 1.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 1.1 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 0.8 | GO:0009265 | 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.2 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.2 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.2 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.2 | 0.2 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.2 | 0.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 1.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.3 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.1 | GO:0015810 | aspartate transport(GO:0015810) |
0.1 | 0.6 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.6 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.1 | 1.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.5 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.5 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.3 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.3 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.1 | 1.6 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 1.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.3 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.3 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.3 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.4 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.2 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 0.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 1.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.6 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.6 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.3 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 1.1 | GO:0036474 | cell death in response to hydrogen peroxide(GO:0036474) regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.1 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.2 | GO:0035810 | regulation of urine volume(GO:0035809) positive regulation of urine volume(GO:0035810) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 1.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 1.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 1.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 1.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.8 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.6 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 0.3 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.1 | 0.8 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 4.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.1 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 1.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 4.3 | GO:0008037 | cell recognition(GO:0008037) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.3 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 2.3 | GO:0007611 | learning or memory(GO:0007611) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.6 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.6 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.1 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.1 | 0.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.5 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.4 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.0 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 1.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.0 | GO:0032071 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.0 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.2 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 1.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.0 | 0.0 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.1 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.0 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.0 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.0 | 0.0 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.0 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.0 | 0.0 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.0 | GO:0010878 | cholesterol storage(GO:0010878) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.0 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.1 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.0 | GO:0019098 | reproductive behavior(GO:0019098) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 19.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
4.3 | 21.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
3.7 | 36.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
3.6 | 43.0 | GO:0043194 | axon initial segment(GO:0043194) |
3.3 | 9.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.2 | 9.7 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.2 | 12.9 | GO:1990696 | USH2 complex(GO:1990696) |
2.9 | 8.7 | GO:0097427 | microtubule bundle(GO:0097427) |
2.8 | 22.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.6 | 15.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.5 | 25.2 | GO:0060091 | kinocilium(GO:0060091) |
2.2 | 34.9 | GO:0030673 | axolemma(GO:0030673) |
2.2 | 8.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
2.1 | 12.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.1 | 52.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
2.0 | 22.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.9 | 7.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.9 | 21.0 | GO:0042555 | MCM complex(GO:0042555) |
1.9 | 5.7 | GO:0072534 | perineuronal net(GO:0072534) |
1.7 | 13.9 | GO:0097449 | astrocyte projection(GO:0097449) |
1.7 | 25.0 | GO:0031527 | filopodium membrane(GO:0031527) |
1.6 | 4.9 | GO:0000322 | storage vacuole(GO:0000322) |
1.6 | 22.6 | GO:0031045 | dense core granule(GO:0031045) |
1.6 | 27.4 | GO:0097440 | apical dendrite(GO:0097440) |
1.6 | 8.0 | GO:0061617 | MICOS complex(GO:0061617) |
1.6 | 4.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.5 | 6.1 | GO:0042827 | platelet dense granule(GO:0042827) |
1.5 | 92.8 | GO:0030175 | filopodium(GO:0030175) |
1.5 | 9.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.5 | 49.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.4 | 6.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.3 | 6.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.3 | 8.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.2 | 2.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.2 | 3.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.2 | 12.7 | GO:0032039 | integrator complex(GO:0032039) |
1.2 | 6.9 | GO:0044327 | dendritic spine head(GO:0044327) |
1.1 | 3.3 | GO:0048179 | activin receptor complex(GO:0048179) |
1.1 | 47.5 | GO:0005871 | kinesin complex(GO:0005871) |
1.1 | 29.6 | GO:0031941 | filamentous actin(GO:0031941) |
1.0 | 9.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.0 | 10.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
1.0 | 3.9 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.9 | 12.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.9 | 7.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 2.8 | GO:0044308 | axonal spine(GO:0044308) |
0.9 | 2.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.9 | 7.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.9 | 6.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.8 | 8.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.8 | 8.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.8 | 2.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 6.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 3.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.8 | 27.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 4.7 | GO:0051286 | cell tip(GO:0051286) |
0.8 | 4.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.8 | 3.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.7 | 6.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 4.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.7 | 2.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.7 | 3.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 3.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.7 | 2.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.7 | 2.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 3.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.7 | 4.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.7 | 6.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.7 | 1.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.7 | 4.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 5.5 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 4.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.7 | 2.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 1.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.6 | 6.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 8.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.6 | 9.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.6 | 94.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 13.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.6 | 8.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.6 | 27.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.6 | 5.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 5.7 | GO:0032797 | SMN complex(GO:0032797) |
0.6 | 6.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 1.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 1.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 30.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 10.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 1.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 7.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 1.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.5 | 4.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.5 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 0.9 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 1.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 1.4 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 1.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.4 | 1.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 12.1 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 1.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 6.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.4 | 6.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 1.2 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.4 | 6.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 1.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 3.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 1.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 35.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.4 | 1.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 3.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 1.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.4 | 10.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 7.3 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 1.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 3.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 1.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 1.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 3.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 5.7 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 1.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 4.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 19.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.3 | 3.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 0.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 1.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.3 | 2.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 1.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 0.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 1.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 3.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 2.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.3 | 6.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 2.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.2 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 13.2 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 1.6 | GO:0070187 | telosome(GO:0070187) |
0.2 | 2.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 28.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 0.9 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.2 | 0.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 25.0 | GO:0030424 | axon(GO:0030424) |
0.2 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 1.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 3.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 6.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 2.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.2 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.4 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 8.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 14.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 2.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 2.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 1.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 1.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 7.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 1.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 7.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 1.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 4.3 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 1.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.9 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 10.9 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 1.5 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 1.8 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.7 | 38.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
7.2 | 21.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
6.7 | 20.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
5.7 | 17.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
5.5 | 27.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
5.3 | 15.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.1 | 15.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.2 | 12.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
3.6 | 18.1 | GO:1990254 | keratin filament binding(GO:1990254) |
3.4 | 3.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
3.3 | 26.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.2 | 12.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.1 | 9.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.0 | 33.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
2.9 | 8.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.9 | 17.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.9 | 11.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.7 | 10.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.5 | 25.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
2.4 | 30.9 | GO:0031005 | filamin binding(GO:0031005) |
2.3 | 6.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.3 | 9.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
2.2 | 4.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.2 | 8.8 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
2.1 | 23.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.1 | 8.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.0 | 10.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.0 | 3.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.9 | 13.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.9 | 26.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.9 | 9.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.9 | 7.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.9 | 27.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.8 | 35.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.8 | 12.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.8 | 10.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.8 | 5.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.8 | 12.3 | GO:0030957 | Tat protein binding(GO:0030957) |
1.7 | 8.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.7 | 7.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.7 | 12.2 | GO:0003680 | AT DNA binding(GO:0003680) |
1.7 | 7.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.7 | 8.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.7 | 5.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.7 | 5.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.7 | 10.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.7 | 1.7 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.6 | 1.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.6 | 4.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.6 | 6.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.6 | 14.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.6 | 9.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.5 | 6.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.5 | 37.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.5 | 4.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.5 | 9.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.5 | 4.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.5 | 4.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.5 | 1.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.5 | 10.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.5 | 22.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.5 | 5.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.4 | 4.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.4 | 1.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.4 | 16.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.4 | 5.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.3 | 4.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.3 | 6.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.3 | 10.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.3 | 3.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.3 | 5.0 | GO:0071253 | connexin binding(GO:0071253) |
1.2 | 3.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.2 | 3.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.2 | 9.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.2 | 21.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
1.2 | 3.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.2 | 4.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.2 | 5.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.2 | 57.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
1.2 | 14.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.2 | 3.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.2 | 3.5 | GO:0016015 | morphogen activity(GO:0016015) |
1.1 | 2.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.1 | 2.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.1 | 3.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.1 | 6.7 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 5.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.1 | 3.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.1 | 3.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.1 | 4.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.0 | 12.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.0 | 3.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.0 | 1.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.0 | 3.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.0 | 13.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.0 | 2.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 4.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.0 | 7.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 2.9 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.0 | 6.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.9 | 20.2 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.9 | 2.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.9 | 18.3 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.9 | 18.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.9 | 2.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.9 | 2.7 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.9 | 3.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.9 | 3.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.9 | 6.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.9 | 2.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.9 | 4.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.9 | 2.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 1.7 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.9 | 2.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.9 | 6.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.9 | 1.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 4.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.8 | 3.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 4.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 4.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.8 | 2.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.8 | 0.8 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.8 | 10.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.8 | 22.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.8 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 12.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.8 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 7.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 6.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.8 | 2.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 3.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.8 | 3.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.8 | 9.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.7 | 4.5 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 20.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 6.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 2.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.7 | 2.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 12.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 7.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 7.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.7 | 8.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.7 | 3.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.7 | 5.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 1.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.7 | 3.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.7 | 20.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 3.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 10.8 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 6.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.7 | 8.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.7 | 2.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.7 | 2.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 15.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.6 | 1.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 16.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 5.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.6 | 7.0 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 4.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.6 | 2.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 3.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 30.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.6 | 6.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 6.2 | GO:0008061 | chitin binding(GO:0008061) |
0.6 | 1.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.6 | 4.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 1.8 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.6 | 2.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 13.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 3.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.6 | 2.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 2.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 1.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.6 | 2.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 16.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.6 | 1.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.6 | 2.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.6 | 2.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.6 | 7.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.5 | 2.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 10.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.5 | 9.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.5 | 4.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 2.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 3.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.5 | 1.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 3.6 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 2.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 1.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.5 | 3.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.5 | 4.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 0.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 3.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 7.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 4.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 5.2 | GO:0043899 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.5 | 11.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.5 | 8.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.5 | 1.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.5 | 8.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 11.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 16.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.4 | 5.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 19.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 4.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 0.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.4 | 4.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 4.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 9.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 1.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 4.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.4 | 9.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 4.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 0.8 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 3.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.4 | 4.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 10.5 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.4 | 2.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 1.6 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 26.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 4.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 4.4 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.4 | 4.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 3.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.4 | 1.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 4.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 2.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.4 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 38.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.4 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 1.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 10.4 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.3 | 0.7 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.3 | 11.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 8.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 6.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.0 | GO:0008495 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.3 | 1.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 1.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 8.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 1.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 4.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 1.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 1.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 1.0 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 1.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 1.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 1.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 6.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 2.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 2.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 7.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.3 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 2.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 1.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 1.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 3.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 3.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 8.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 2.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 1.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 2.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 1.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 2.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.3 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 1.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 5.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 1.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 0.8 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 17.6 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.3 | 1.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 1.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 0.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 1.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 3.6 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.3 | 1.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.3 | 1.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 1.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.7 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 4.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.9 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.2 | 0.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 2.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 1.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 1.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.4 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 8.8 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 4.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.2 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 2.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.2 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.6 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 4.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 2.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 4.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 5.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 5.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 3.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 4.7 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 1.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 0.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 2.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 3.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 1.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.2 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.2 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 3.9 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 6.3 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 1.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.3 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 1.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.5 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 1.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 2.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 1.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 2.1 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 4.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 3.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.3 | GO:0043759 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 1.0 | GO:0052768 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 1.4 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 4.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
2.0 | 27.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.9 | 30.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 15.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 25.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.9 | 17.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.8 | 16.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 29.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.8 | 12.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 1.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 18.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.7 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 5.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.6 | 29.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.6 | 13.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 12.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 16.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.5 | 12.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 3.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 2.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 3.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 9.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 13.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 1.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 4.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 6.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 14.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 14.8 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 14.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 17.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 5.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 4.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 7.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 4.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 5.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 7.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 2.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.3 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 6.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 2.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 12.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 3.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 4.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 5.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 5.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 3.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 28.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 15.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 7.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 63.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.0 | 22.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.9 | 22.4 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
1.5 | 13.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.4 | 38.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.4 | 11.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.4 | 29.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.4 | 22.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.4 | 15.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.4 | 5.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.3 | 24.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.3 | 34.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
1.2 | 10.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.2 | 19.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.1 | 2.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.1 | 6.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.0 | 16.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.0 | 11.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.0 | 13.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.0 | 25.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.0 | 9.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.9 | 25.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.9 | 8.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.9 | 22.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 8.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.9 | 12.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.9 | 35.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.8 | 2.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 2.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.8 | 5.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.8 | 19.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.8 | 3.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.7 | 7.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 9.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.7 | 16.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 4.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 4.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 7.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 7.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 6.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 22.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 7.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 7.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 5.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.5 | 1.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.5 | 2.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.5 | 2.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 2.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 2.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 3.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 20.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.4 | 9.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 8.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 5.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 18.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.4 | 2.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 3.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 5.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 2.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 4.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 9.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 6.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 10.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 23.4 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.3 | 2.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 3.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 16.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 2.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 1.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 1.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 3.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 5.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 2.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 2.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 2.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 3.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 2.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 0.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 8.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 2.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 3.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.4 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 1.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |